- ►annals.org [PDF] G Salanti, FK Kavvoura, J Ioannidis - Annals of internal medicine, 2008 - Am Coll Physicians Page 1. Exploring the Geometry of Treatment Networks Georgia Salanti, PhD;
Fotini K. Kavvoura, MD; and John PA Ioannidis, MD Background ... Cited by 10 - Related articles - BL Direct - All 4 versions
G Salanti, J Higgins, AE Ades, J Ioannidis - Statistical methods in medical research, 2008 - smm.sagepub.com Randomized trials may be designed and interpreted as single experiments or they
may be seen in the context of other similar or relevant evidence. The amount and
complexity of available randomized evidence vary for different topics. ... Cited by 21 - Related articles - All 3 versions
JPA Ioannidis - The Lancet, 2006 - Elsevier In this mesh, two treatments might never be compared head-to-head, but both
might have been tested against some common comparators—eg, placebo, no
treatment, or other agents. 1 Sometimes, head-to-head assessments are done ... Cited by 22 - Related articles - All 4 versions
G Salanti, V Marinho, JPT Higgins - Journal of Clinical Epidemiology, 2009 - Elsevier OBJECTIVE: To illustrate the potential and challenges of the simultaneous
analysis of a network of trials, using as a case study the investigation of the
relative effectiveness of four topical fluoride treatments and two control ... Cited by 3 - Related articles - All 17 versions
D Mauri, NP Polyzos, G Salanti, N Pavlidis, J … - JNCI Journal of the National Cancer Institute, 2008 - jnci.oxfordjournals.org Methods: We performed a systematic review of all trials that compared different
regimens involving chemotherapy and/or targeted therapy in advanced breast
cancer (1973–2007). Regimens were categorized a priori into different ... Cited by 6 - Related articles - All 10 versions
F Song, I Harvey, R Lilford - Journal of Clinical Epidemiology, 2008 - Elsevier In all the three cases, effects of new drugs estimated by head-to-head trials
tend to be greater than that by adjusted indirect comparisons. The observed
discrepancies could not be satisfactorily explained by the play of chance ... Cited by 5 - Related articles - All 13 versions
SG Baker, BS Kramer - BMC Medical Research Methodology, 2002 - biomedcentral.com If intervention A bests B in one randomized trial, and B bests C in another
randomized trial, can one conclude that A is better than C? The problem was
motivated by the planning of a randomized trial, where A is spiral-CT ... Cited by 17 - Related articles - Cached - All 8 versions
B Schöttker, D Lühmann, D Boulkhemair, H … - gripsdb.dimdi.de Die HTA-Berichte des DIMDI durchlaufen ein unabhängiges, grundsätzlich
anonymisiertes Gutachter- verfahren. Potentielle Interessenkonflikte bezüglich
der HTA-Berichte werden dem DIMDI von den Autoren und den Gutachtern ... Related articles - All 2 versions
C O'Regan, I Ghement, O Eyawo, GH Guyatt, … - Trials, 2009 - pubmedcentral.nih.gov Comparing the effectiveness of interventions is now a requirement for regulatory
approval in several countries. It also aids in clinical and public health
decision-making. However, in the absence of head-to-head randomized trials ... Related articles - All 7 versions
L Manzoli, G Salanti, C De Vito, A Boccia, JPA … - The Lancet Infectious Diseases, 2009 - Elsevier Influenza H5N1 is thought to be a likely causative agent for a future human
influenza pandemic. Several types of H5N1 vaccine have been tested, including
different doses and adjuvants, and a meta-analysis is needed to identify ... Related articles - All 22 versions
